| Literature DB >> 23185499 |
Nadine Schmid1, Gabriella Pessi, Yinyue Deng, Claudio Aguilar, Aurelien L Carlier, Alexander Grunau, Ulrich Omasits, Lian-Hui Zhang, Christian H Ahrens, Leo Eberl.
Abstract
Quorum sensing in Burkholderia cenocepacia H111 involves two signalling systems that depend on different signal molecules, namely N-acyl homoserine lactones (AHLs) and the diffusible signal factor cis-2-dodecenoic acid (BDSF). Previous studies have shown that AHLs and BDSF control similar phenotypic traits, including biofilm formation, proteolytic activity and pathogenicity. In this study we mapped the BDSF stimulon by RNA-Seq and shotgun proteomics analysis. We demonstrate that a set of the identified BDSF-regulated genes or proteins are also controlled by AHLs, suggesting that the two regulons partially overlap. The detailed analysis of two mutually regulated operons, one encoding three lectins and the other one encoding the large surface protein BapA and its type I secretion machinery, revealed that both AHLs and BDSF are required for full expression, suggesting that the two signalling systems operate in parallel. In accordance with this, we show that both AHLs and BDSF are required for biofilm formation and protease production.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23185499 PMCID: PMC3502180 DOI: 10.1371/journal.pone.0049966
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Mapping of the BDSF stimulon.
(A) MA plot showing the fold change in transcript expression of all B. cenocepacia H111 genes versus the mean of identified reads in an rpfF Bc mutant and wild type. The 112 down-regulated transcripts/proteins in the rpfF Bc mutant are indicated in red, the 38 up-regulated genes in green. (B) Box plot demonstrating that supplementing the medium with 10 µM BDSF rescues the gene expression defects in the rpfF Bc mutant.
List of genes and proteins differentially expressed using RNA-Seq and proteomics in the rpfF mutant compared to the wild type.
| RNA Seq | Proteomics | ||||||
| Locus ID CCE | Orthologues J2315 | Description | Gene name | wt vs | wt vs | wt vs | wt vs |
| CCE49245 | BCAL0111 | O-linked N-acetylglucosamine transferase | 3.0 | 2.1 | na | 2.8 | |
| CCE46674 | BCAL0249 | 50S ribosomal protein L6 | 0.4 | 0.9 | 1.6 | 1.5 | |
| CCE48190 | BCAL0524 | Flagellar motor switch protein | 5.1 | 3.2 | 3.9 | 1.4 | |
| CCE48189 | BCAL0525 | Flagellar MS-ring protein | 4.2 | 6.5 | 2.9 | 1.6 | |
| CCE53354 | BCAL0762 | Methyl-Apting chemotaxis protein | 4.6 | 1.4 | 2.7 | 0.9 | |
| CCE53285 | BCAL0831 | Phasin family protein | 2.9 | 0.7 | 3.2 | 1.4 | |
| CCE51557 | BCAL1059 | Bifunctional N-succinyldiaminopimelate-aminotransferase/acetylornithine transaminase protein | 2.8 | 1.6 | 0.5 | 0.8 | |
| CCE50475 | BCAL2352 | Carbonic anhydrase | 4.3 | 1.0 | 7.0 | 1.1 | |
| CCE49840 | BCAL3041 | Protein involved in carbohydrate transport | 4.5 | 2.0 | 0.5 | 1.6 | |
| CCE51244 | BCAL3285 | Nitric oxide dioxygenase; flavohemoprotein | 6.7 | 0.6 | na | 0.8 | |
| CCE46722 | BCAM0184 | Fucose-Binding lectin protein |
| 183.0 | 0.5 | na | 0.8 |
| CCE46720 | BCAM0186 | Fucose-Binding lectin protein |
| 280.2 | 0.5 | na | 1.1 |
| CCE46715 | BCAM0191 | Non-ribosomal peptide synthetase | 5.2 | 0.9 | na | 0.7 | |
| CCE46713 | BCAM0192 | 9.4 | 1.5 | na | 1.2 | ||
| CCE46711 | BCAM0194 | 7.9 | 1.6 | na | 0.4 | ||
| CCE46710 | BCAM0195 | Non-ribosomal peptide synthetase | 6.6 | 1.4 | na | 0.8 | |
| CCE46709 | BCAM0196 | 5.9 | 0.9 | 14.0 | 0.9 | ||
| CCE50899 | BCAM0853 | Transposase | 3.1 | 0.8 | 10.0 | 0.7 | |
| CCE50898 | BCAM0854 | Mannose-6-phosphate isomerase | 8.3 | 0.4 | na | 0.4 | |
| CCE50892 | BCAM0859 | Protein involved in capsule organization | 31.8 | 0.4 | na | 0.7 | |
| CCE48736 | BCAM1004 | Gdp-Mannose 4,6-dehydratase | 4.3 | 0.3 | na | 0.5 | |
| CCE47169 | BCAM1572 | Methyl-Apting chemotaxis protein | 3.0 | 1.2 | 3.0 | 1.5 | |
| CCE46959 | BCAM1745 | Atpase | 0.01 | 0.8 | 0.2 | 2.2 | |
| CCE53120 | BCAM2140 | Type I secretion membrane fusion protein | 15.8 | 1.0 | na | 1.4 | |
| CCE53119 | BCAM2141 | ABC transporter protein | 16.0 | 0.9 | na | 1.0 | |
| CCE53117 | BCAM2143 | Calcium ion binding protein |
| 12.2 | 0.8 | 41.5 | 0.7 |
| CCE53024 | BCAM2224 | Protein involved in siderophore transport | 31.5 | 28.0 | na | na | |
| CCE53019 | BCAM2230 | Non-ribosomal peptide synthetase | 11.8 | 7.9 | na | na | |
| CCE46201 | BCAM2627 | Protein involved in iron ion transport | 6.2 | 11.0 | 10.0 | 10.0 | |
Nomenclature according to GenBank file CAFQ01000001.1.
Orthologs were identified as described in the Material and Methods section.
Description according to the EggNOG classification.
Fold change (FC) of transcript expression, comparing wild type strain with rpfF mutant grown in LB medium until an OD of 2.
Fold change (FC) of transcript expression, comparing wild type strain with complemented rpfF mutant grown in LB medium until an OD of 2.
Fold change (FC) of protein expression, comparing wild type strain with rpfF mutant grown in LB medium until an OD of 2.
Fold change (FC) of protein expression, comparing wild type strain with complemented rpfF mutant grown in LB medium until an OD of 2.
na, not applicable because the read number or spectral counts in the mutant or complemented strains is equal 0.
List of genes differentially expressed in the rpfF and cepR mutant, using the wild type as baseline.
| Locus ID CCE | Orthologues J2315 | Description | Gene name | wt vs | wt vs | wt vs |
| CCE49231 | BCAL0124 | Transcriptional activator FlhD | 3.7 | 1.5 | 0.5 | |
| CCE53285 | BCAL0831 | Phasin family protein | 2.8 | 0.7 | 3.2 | |
| CCE52825 | BCAL0833 | Acetoacetyl-Coa reductase | 4.3 | 1.1 | 3.0 | |
| CCE51553 | BCAL1063 | Succinylarginine dihydrolase | 2.8 | 1.4 | 0.5 | |
| CCE50476 | BCAL2353 | Sulfate permease | 18.4 | 0.9 | 2.2 | |
| CCE51244 | BCAL3285 | Nitric oxide dioxygenase; flavohemoprotein | 6.5 | 0.6 | 25.8 | |
| CCE46722 | BCAM0184 | Fucose-Binding lectin protein |
| 181.0 | 0.5 | 5.1 |
| CCE46721 | BCAM0185 | Fucose-Binding lectin protein |
| 73.5 | 0.7 | 3.3 |
| CCE46720 | BCAM0186 | Fucose-Binding lectin protein |
| 274.4 | 0.5 | 9.0 |
| CCE46715 | BCAM0191 | Non-ribosomal peptide synthetase | 5.3 | 0.9 | 12.8 | |
| CCE46713 | BCAM0192 | 9.2 | 1.5 | 46.8 | ||
| CCE46712 | BCAM0193 | 17.1 | 2.3 | 47.7 | ||
| CCE46711 | BCAM0194 | 8.0 | 1.6 | 52.2 | ||
| CCE46710 | BCAM0195 | Non-ribosomal peptide synthetase | 6.5 | 1.4 | 34.0 | |
| CCE46709 | BCAM0196 | 6.1 | 0.9 | 37.7 | ||
| CCE50917 | BCAM0835 | Transcriptional regulator, AraC family protein | 4.9 | 1.2 | 4.3 | |
| CCE48735 | BCAM1005 | Acyltransferase | 4.6 | 0.6 | 2.2 | |
| CCE48728 | BCAM1010 | Utp–Glucose-1-Phosphate uridylyltransferase | 39.4 | 0.5 | 2.4 | |
| CCE46959 | BCAM1745 | Atpase | 0.01 | 0.8 | 0.4 | |
| CCE50321 | BCAM1871 | 3-Hydroxy-3-Methylglutaryl-Coenzyme A reductase | 3.5 | 0.8 | 32.5 | |
| CCE53256 | BCAM2060 | Natural resistance-associated macrophage protein | 0.1 | 0.8 | 0.4 | |
| CCE53120 | BCAM2140 | Type I secretion membrane fusion protein | 16.0 | 0.9 | 3.1 | |
| CCE53119 | BCAM2141 | ABC transporter protein | 16.0 | 0.9 | 4.4 | |
| CCE53118 | BCAM2142 | 14.9 | 1.0 | 5.3 | ||
| CCE53117 | BCAM2143 | Calcium ion binding protein | 12.1 | 0.8 | 5.1 | |
| CCE53089 | BCAM2169 | Outer membrane autotransporter protein | 2.6 | 0.9 | 2.1 | |
| CCE53021 | BCAM2227 | Pyochelin biosynthetic protein | na | na | 2.2 | |
| CCE52940 | BCAM2307 | Metalloendopeptidase |
| 3.7 | 1.4 | 8.7 |
| CCE52939 | BCAM2308 | Aminopeptidase | 4.0 | 1.5 | 5.3 | |
| CCE52108 | BCAS0292 |
| 3.2 | 0.9 | 138.1 | |
| CCE52109 | BCAS0293 |
| 4.0 | 0.8 | 167.2 |
Nomenclature according to GenBank file CAFQ01000001.1.
Orthologs were identified as described in the Material and Methods section.
Description according to EggNOG categories.
Fold change (FC) of expression, comparing wild type strain with rpfF mutant grown in LB medium until an OD of 2.
Fold change (FC) of expression, comparing wild type strain with complemented rpfF mutant grown in LB medium until an OD of 2.
Fold change (FC) of expression comparing wild type strain with cepR mutant grown in LB medium until an OD of 2 [11].
na, not applicable because the read number in the mutant or complemented strains is equal 0.
Validation of RNA-Seq results using quantitative PCR analysis.
| Locus ID CCE | Orthologues J2315 | Description | gene name | wt vs | wt vs | wt vs | wt vs |
| CCE46720 | BCAM0186 | Fucose-Binding lectin protein |
| 74 | 1.2 | 4.1 | 0.4 |
| CCE48446 | BCAM0581 | Enoyl-CoA hydratase/carnithine racemase |
| 0.6 | 0.3 | 0.7 | 0.8 |
| CCE48447 | BCAM0580 | EAL/GGDEF domain protein |
| 1 | 0.6 | 0.8 | 0.5 |
| CCE50322 | BCAM1870 | N-acyl-L-homoserine lactone synthetase |
| 3.2 | 1.6 | 65.0 | 0.8 |
| CCE50324 | BCAM1868 | Transcriptional regulator protein |
| 1.7 | 1.8 | 0.6 | 0.3 |
| CCE50476 | BCAL2353 | Sulfate permease | 6 | 1.8 | 4.2 | 1.1 | |
| CCE50898 | BCAM0854 | Mannose-6-phosphate isomerase | 11.3 | 1 | 6.3 | 0.6 | |
| CCE52109 | BCAS0293 | AidA |
| 6 | 1.8 | 685.0 | 0.5 |
Nomenclature according to GenBank file CAFQ01000001.1.
Orthologs were identified as described in the Material and Methods section.
Description according to EggNOG classification.
Fold change (FC) of expression, comparing wild type strain with rpfF mutant grown in LB medium until an OD of 2.
Fold change (FC) of expression, comparing wild type strain with complemented rpfF mutant grown in LB medium until an OD of 2.
Fold change (FC) of expression comparing wild type strain with cepR mutant grown in LB medium until an OD of 2.
Fold change (FC) of expression, comparing wild type strain with complemented cepR mutant grown in LB medium until an OD of 2.
Figure 2The role of the two QS systems in the regulation of selected genes.
The bapA (A), bclA (B), and aidA (C) promoter activities were assessed by means of transcriptional lacZ fusions in the H111 wild type strain and in the mutant defective in AHL and BDSF synthesis (ΔcepI rpfF Bc). The strains were grown to late exponential growth phase in LB Lennox broth in the absence or presence of signal molecules (200 nM C8-HSL; 10 µM BDSF) as indicated by+and - below each bar. Error bars indicate SEM, n = 3. * P<0.05, ** P<0.01, *** P<0.001 (t-test, two-tailed) compared to ΔcepI rpfF Bc without signalling molecule (ns, not significant) (D) Expression of BclB and AidA in the H111 wild type and the double mutant ΔcepI rpfF as assessed by Western Blot analysis. The strains were grown on plates in the presence or absence of signal molecules as indicated by+and - below each band.
Figure 3AHL-levels are reduced in an rpfF mutant.
The amount of AHLs produced by the cepI and the rpfF mutant with cepI constitutively expressed from plasmid pBBRcepI or with the empty plasmid control pBBR1MCS5 was quantified by the aid of the biosensor P. putida/pAS-C8. Error bars indicate SEM, n≥3.
Figure 4Biofilm formation and protease activity are co-regulated by AHL and BDSF.
(A) Biofilm formation in ABC minimal. (B) Protease activity in NYG medium. The strains tested are the wild type H111 and the cepI rpfF Bc double mutant. Strains were grown in the presence of absence of signal molecules (200 nM C8-HSL; 10 µM BDSF) as indicated by+and - below each bar. Error bars indicate SEM, n≥3. ** P<0.01, *** P<0.001 (t-test, two-tailed) compared to ΔcepI rpfF Bc without signalling molecule (ns, not significant).
Figure 5Schematic presentation of the two B. cenocepacia H111 QS circuitries.
The CepI/CepR system consists of the AHL synthase CepI directing the synthesis of C8-HSL, and of the transcriptional regulator CepR. The RpfF/RpfR system consists of RpfF which directs the synthesis of BDSF, and of its cognate receptor RpfR. Upon binding of BDSF to RpfR the c-di-GMP phosphodiesterase activity of the protein is stimulated and as a consequence the intracellular c-di-GMP level is lowered. The two QS systems operate in parallel to control specific as well as overlapping sets of genes. Our working model assumes an unknown c-di-GMP receptor protein × that stimulates transcription of target genes. Alternatively, the two QS cascades converge and control the expression or the activity status of an unknown common regulator Y, which in turn regulates expression of target genes. C-di-GMP has a negative regulatory effect on AHL levels via an unknown mechanism (depicted by the dashed line).